Skip to main content
Research

Publications: Dr Julie Foster

Pistorius K, Ly L, Souza PR, Gomez EA, Koenis DS, Rodriguez AR, Foster J, Sosabowski J et al. ( 2022 ) . MCTR3 reprograms arthritic monocytes to upregulate Arginase-1 and exert pro-resolving and tissue-protective functions in experimental arthritis . eBioMedicine vol. 79 ,
Dexter K, Foster J, Sosabowski J, Petrik M ( 2022 ) . Preclinical PET and SPECT Instrumentation . Nuclear Medicine and Molecular Imaging ,
Dexter K, Foster J, Petrik M, Sosabowski J ( 2022 ) . Preclinical PET and SPECT imaging . Nuclear Medicine and Molecular Imaging ,
Borràs J, Foster J, Kashani R, Meléndez-Alafort L, Sosabowski J, Suades J, Barnadas-Rodríguez R ( 2021 ) . New bioconjugated technetium and rhenium folates synthesized by transmetallation reaction with zinc derivatives . Molecules vol. 26 , ( 8 )
Borràs J, Lecina J, Foster J, Kashani R, Melendez-Alafort L, Sosabowski J, Suades J ( 2021 ) . Bioconjugated technetium carbonyls by transmetalation reaction with zinc derivatives . Bioorganic and Medicinal Chemistry Letters vol. 37 ,
Dexter K, BROWN N, Foster J, Kashani R, CHUPIN J, Cleaver J, Cutmore L, Marshall J et al. ( 2020 ) . Simultaneous dual isotope PET-SPECT/CT imaging of pancreatic cancer . Presented at: EMIM 2020 , Abstract: java.sql.Clob org.hibernate.engine.jdbc.WrappedClob java.io.Serializable ,
Pavlyk I, Foster J, Dexter K, Sobasowski J, Bomalarski J, Berlato C, Balkwill F, Szlosarek PW ( 2020 ) . Abstract 2217: Pegylated arginine deiminase sensitizes ASS1-negative and KRAS mutant non-small cell lung cancer to PD-1 blockade immunotherapy . Cancer Research . vol. 80 , 2217 - 2217 .
Demircioglu F, Wang J, Candido J, Costa ASH, Casado P, de Luxan Delgado B, Reynolds LE, Gomez-Escudero J et al. ( 2020 ) . Cancer associated fibroblast FAK regulates malignant cell metabolism . Nature Communications vol. 11 , ( 1 ) 1290 - 1290 .
Stella Man YK, Foster J, Carapuça E, Davies JA, Parker AL, Sosabowski J, Halldén G ( 2019 ) . Systemic delivery and SPECT/CT in vivo imaging of <sup>125</sup>I-labelled oncolytic adenoviral mutants in models of pancreatic cancer . Scientific Reports vol. 9 , ( 1 )
Crnogorac-Jurcevic T, Radon T, Shah S, Weeks M, Foster J, Sosabowski J, Dumartin L ( 2019 ) . AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting . Oncotarget
Zhai C, He S, Chen X, Lu J, Rangger C, Summer D, Haas H, Foster J et al. ( 2019 ) . Synthesis and comparison of novel fusarinine C-based chelators for Zr-89-labeling . JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS . vol. 62 , S35 - S36 .
Zhai C, He S, Ye Y, Rangger C, Kaeopookum P, Summer D, Haas H, Kremser L et al. ( 2019 ) . Rational design, synthesis and preliminary evaluation of novel fusarinine C-based chelators for radiolabeling with Zirconium-89 . Biomolecules vol. 9 , ( 3 )
Klingler M, Summer D, Rangger C, Haubner R, Foster J, Sosabowski J, Decristoforo C, Virgolini I et al. ( 2019 ) . DOTA-MGS5, a new cholecystokinin-2 receptor-targeting peptide analog with an optimized targeting profile for theranostic use . Journal of Nuclear Medicine vol. 60 , ( 7 ) 1010 - 1016 .
Klingler M, Decristoforo C, Rangger C, Summer D, Foster J, Sosabowski JK, Von Guggenberg E ( 2019 ) . Erratum: Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting (Theranostics(2018) 8:11 (2896-2908) DOI: 10.7150/thno.24378) . Theranostics vol. 9 , ( 16 ) 4595 - 4596 .
Rudran B, Reader C, Foster J, Hodivala-Dilke K, Sosabowski J, Marshall J ( 2018 ) . P1.03-19 Antibody Blockade of Integrin Alpha-V-Beta-6 (avb6) as a Novel Treatment for NSCLC . Journal of Thoracic Oncology . vol. 13 , s518 - s519 .
Pouget J, Deshayes E, Ladjohounlou R, le Fur P, Pichard A, Lozza C, Kashani R, Koch J et al. ( 2018 ) . Theranostic approach in ovarian cancer using Anti-MISRII radiolabeled antibodies . EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING . vol. 45 , S616 - S617 .
Deshayes E, Ladjohounlou R, Le Fur P, Pichard A, Lozza C, Boudousq V, Sevestre S, Jarlier M et al. ( 2018 ) . Radiolabeled antibodies against Müllerian-inhibiting substance receptor, type II: New tools for a theranostic approach in ovarian cancer . Journal of Nuclear Medicine vol. 59 , ( 8 ) 1234 - 1242 .
Klingler M, Decristoforo C, Rangger C, Summer D, Foster J, Sosabowski JK, von Guggenberg E ( 2018 ) . Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting . Theranostics vol. 8 , ( 11 ) 2896 - 2908 .
Emami-Shahri N, Foster J, Kashani R, Gazinska P, Cook C, Sosabowski J, Maher J, Papa S ( 2018 ) . Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells . Nature Communications vol. 9 , ( 1 ) 1081 - 1081 .
Rudran B, Reader C, Foster J, Hodivala-Dilke K, Sosabowski J, Marshall J ( 2018 ) . Blockade of integrin alpha-v-beta-6 (alpha v beta 6) reduces the invasive potential of NSCLC . LUNG CANCER . vol. 115 , S5 - S6 .
Ahmed W, Barker SA, Sosabowski J, Foster JM, Soanes R, Hartman N ( 2017 ) . Evaluation of the physicochemical properties of (99m)Technetium-Exametazime (Medi-Exametazime (TM)) and its biodistribution in a pre-clinical mouse model . EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING . vol. 44 , S544 - S544 .
Klingler M, Rangger C, Summer D, Foster J, Sosabowski JK, von Guggenberg E ( 2017 ) . New radiolabelled minigastrin analogues with improved CCK2R targeting for diagnostic and therapeutic use . EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING . vol. 44 , S228 - S228 .
Mak C, Barker SA, Sosabowski JK, Foster JM, Hartman NG ( 2017 ) . Stability assessment after reconstitution and investigation of the biodistribution in a pre-clinical mouse model of 99mTechnetium-Sestamibi (Cardiovis (TM)) . EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING . vol. 44 , S543 - S544 .
Rudran B, Desai A, Luzarraga M, Hodivala-Dilke K, Foster J, Sosabowski J, Marshall J ( 2017 ) . Development of non-invasive imaging of integrin alpha-v-beta-6 (alpha v beta 6)-positive lung cancers in advance of testing alpha v beta 6-targeted therapies . Lung Cancer . Conference: British Thoracic Oncology Group Conference 2017 ( Dublin, Ireland ) from: 25/01/2017 to: 27/01/2017 , vol. 103 , S4 - S4 .
Maher J, Wilkie S, Davies DM, Arif S, Picco G, Julien S, Foster J, Burchell J et al. ( 2016 ) . Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells . Immunity vol. 45 , ( 5 ) 945 - 946 .
Emami-Shahri N, Foster J, Sosabowski J, Maher J, Papa S ( 2016 ) . Abstract 2315: Dynamic SPECT imaging of PSMA-specific CAR T cells in mice bearing prostate cancer . Cancer Research . vol. 76 , 2315 - 2315 .
Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Vadivelu KC, Yip PK, Sosabowski J et al. ( 2016 ) . In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [18F]GE-180 and effect of docosahexaenoic acid . European Journal of Nuclear Medicine and Molecular Imaging
Castillo SD, Tzouanacou E, Zaw-Thin M, Berenjeno IM, Parker VER, Chivite I, Milà-Guasch M, Pearce W et al. ( 2016 ) . Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans . Science Translational Medicine vol. 8 , ( 332 )
Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Trigg W, Sosabowski J, Mather SJ et al. ( 2015 ) . IN VIVO IMAGING OF NEUROINFLAMMATION IN NEUROTRAUMA PRECLINICAL MODELS: POTENTIAL FOR CLINICAL TRANSLATION . SHOCK . vol. 44 , 24 - 25 .
Pujatti PB, Foster JM, Finucane C, Hudson CD, Burnet JC, Pasqualoto KFM, Mengatti J, Mather SJ et al. ( 2015 ) . Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models . Applied Radiation and Isotopes vol. 96 , 91 - 101 .
Parente-Pereira AC, Shmeeda H, Whilding LM, Zambirinis CP, Foster J, van der Stegen SJC, Beatson R, Zabinski T et al. ( 2014 ) . Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2 T cells, potentiated by liposomal alendronic acid . J Immunol vol. 193 , ( 11 ) 5557 - 5566 .
Roosenburg S, Laverman P, Joosten L, Cooper MS, Kolenc-Peitl PK, Foster JM, Hudson C, Leyton J et al. ( 2014 ) . PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with <sup>64</sup>Cu, <sup>68</sup>Ga, and <sup>111</sup>In . Molecular Pharmaceutics vol. 11 , ( 11 ) 3930 - 3937 .
Mullen L, Adams G, Foster J, Vessillier S, Köster M, Hauser H, Layward L, Gould D et al. ( 2014 ) . A comparative study of matrix metalloproteinase and aggrecanase mediated release of latent cytokines at arthritic joints . Ann Rheum Dis vol. 73 , ( 9 ) 1728 - 1736 .
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Marzec J, Vasiljević N, Chaplin T et al. ( 2014 ) . Identification of ZDHHC14 as a novel human tumour suppressor gene . J Pathol vol. 232 , ( 5 ) 566 - 577 .
Allen MD, Luong P, Hudson C, Leyton J, Delage B, Ghazaly E, Cutts R, Yuan M et al. ( 2014 ) . Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging . Cancer Res vol. 74 , ( 3 ) 896 - 907 .
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Marzec J, Vasiljevíc N, Chaplin T et al. ( 2014 ) . Erratum:Identification of ZDHHC14 as a novel human tumour suppressor gene. J Pathol (2014); 232: 566-577)) . Journal of Pathology vol. 234 , ( 1 )
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Marzec J, Vasiljevic N, Chaplin T, Foster JM et al. ( 2014 ) . Identification of ZDHHC14 as a novel human tumour suppressor: gene . INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE vol. 34 , S90 - S90 .
Mullen L, Rigby A, Sclanders M, Adams G, Mittal G, Colston J, Fatah R, Subang C et al. ( 2014 ) . Latency can be conferred to a variety of cytokines by fusion with latency-associated peptide from TGF-β . Expert Opin Drug Deliv vol. 11 , ( 1 ) 5 - 16 .
van der Stegen SJC, Davies DM, Wilkie S, Foster J, Sosabowski JK, Burnet J, Whilding LM, Petrovic RM et al. ( 2013 ) . Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity? . J Immunol vol. 191 , ( 9 ) 4589 - 4598 .
Kogelberg H, Miranda E, Burnet J, Ellison D, Tolner B, Foster J, Picón C, Thomas GJ et al. ( 2013 ) . Generation and characterization of a diabody targeting the αvβ6 integrin . PLoS One vol. 8 , ( 9 )
Coulstock E, Sosabowski J, Ovečka M, Prince R, Goodall L, Mudd C, Sepp A, Davies M et al. ( 2013 ) . Liver-targeting of interferon-alpha with tissue-specific domain antibodies . PLoS One vol. 8 , ( 2 )
Welti JC, Powles T, Foo S, Gourlaouen M, Preece N, Foster J, Frentzas S, Bird D et al. ( 2012 ) . Contrasting effects of sunitinib within in vivo models of metastasis . ANGIOGENESIS vol. 15 , ( 4 ) 623 - 641 .
Joosten L, Sosabowski JK, Cooper MS, Foster J, Burnet J, Oyen WJG, Boerman OC, Blower PJ et al. ( 2012 ) . PET and SPECT Imaging of a CCK2 Receptor-Binding Peptide Comparing Various Chelators and Radionuclides . EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING . vol. 39 , S241 - S241 .
Al-Jamal KT, Nunes A, Methven L, Ali-Boucetta H, Li S, Toma FM, Herrero MA, Al-Jamal WT et al. ( 2012 ) . Degree of chemical functionalization of carbon nanotubes determines tissue distribution and excretion profile . Angew Chem Int Ed Engl vol. 51 , ( 26 ) 6389 - 6393 .
Al‐Jamal KT, Nunes A, Methven L, Ali‐Boucetta H, Li S, Toma FM, Herrero MA, Al‐Jamal WT et al. ( 2012 ) . Degree of Chemical Functionalization of Carbon Nanotubes Determines Tissue Distribution and Excretion Profile . Angewandte Chemie vol. 124 , ( 26 ) 6495 - 6499 .
Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Chaplin T, Xue L, Xu M et al. ( 2012 ) . Abstract 4858: Identification of ZDHHC14 as a novel tumor suppressor gene commonly downregulated in human cancers . Cancer Research vol. 72 , ( 8_Supplement ) 4858 - 4858 .
Davies DM, Foster J, van der Stegen SJC, Parente-Pereira AC, Chiapero-Stanke L, Delinassios GJ, Burbridge SE, Kao V et al. ( 2012 ) . Flexible Targeting of ErbB Dimers That Drive Tumorigenesis by Using Genetically Engineered T Cells . MOLECULAR MEDICINE vol. 18 , ( 4 ) 565 - 576 .
Davies DM, Pereira ACP, van der Stegen SJCT, Brewig N, Foster J, Mather SJ, Wilkie S, Ghaem-Maghami S et al. ( 2011 ) . Flexible targeting of diverse ErbB dimers that drive tumorigenesis using genetically targeted T-cells . HUMAN GENE THERAPY vol. 22 , ( 10 ) A118 - A118 .
van der Stegen SJC, Foster JM, Davies DM, Pereira ACP, Mather SJ, Wilkie S, Maher J ( 2011 ) . In vivo toxicity assessment of genetically-engineered T-cells targeting the ErbB receptor family . HUMAN GENE THERAPY vol. 22 , ( 10 ) A123 - A124 .
Finucane C, Masciotti J, Foster J, McInerney J, Shulman S ( 2011 ) . X-ray CT with Gold Nanoparticles . EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING vol. 38 , S176 - S176 .
Parente-Pereira AC, Burnet J, Ellison D, Foster J, Davies DM, van der Stegen S, Burbridge S, Chiapero-Stanke L et al. ( 2011 ) . Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige mice . J Clin Immunol vol. 31 , ( 4 ) 710 - 718 .
Lopez de Heredia L, Gengatharan A, Foster J, Mather S, Magoulas C ( 2011 ) . Bioluminescence imaging of the brain response to acute inflammation in living C/EBP reporter mice . Neurosci Lett vol. 497 , ( 2 ) 134 - 138 .
Sosabowski J, Coulstock E, Walker A, Sepp A, Kashani R, Foster J, Burnet J, Prince R et al. ( 2011 ) . Biodistribution and microSPECT/CT imaging of In-111-radiolabelled dual targeted domain antibodies . JOURNAL OF NUCLEAR MEDICINE . vol. 52 ,
Sosabowski J, Finucane C, Foster J, Ellison D, Burnet J, Laverman P, Mather S ( 2011 ) . Comparative small animal SPECT/CT imaging of twelve In-111-labelled CCK2-receptor targeting peptides . JOURNAL OF NUCLEAR MEDICINE . vol. 52 ,
Parente-Pereira AC, Burnet J, Ellison D, Foster J, Davies DM, van der Stegen S, Burbridge S, Chiapero-Stanke L et al. ( 2011 ) . Trafficking of CAR-Engineered Human T Cells Following Regional or Systemic Adoptive Transfer in SCID Beige Mice . Journal of Clinical Immunology1 - 9 .
Finucane CM, Murray I, Sosabowski JK, Foster JM, Mather SJ ( 2011 ) . Quantitative Accuracy of Low-Count SPECT Imaging in Phantom and In Vivo Mouse Studies . Int J Mol Imaging vol. 2011 ,
Sosabowski J, Finucane C, Foster J, Ellison D, Burnet J, Mather S ( 2010 ) . Comparison Of 111-In Labelled CCK2-Receptor Targeting Peptides Using Nanospect/CT Imaging, A Collaborative Project Under COST BM0607 . EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING . vol. 37 , S268 - S268 .
Torres Martin de Rosales R, Finucane C, Foster J, Mather SJ, Blower PJ ( 2010 ) . 188Re(CO)3-dipicolylamine-alendronate: a new bisphosphonate conjugate for the radiotherapy of bone metastases . Bioconjug Chem vol. 21 , ( 5 ) 811 - 815 .
Davies DM, Wilkie S, Foster JM, Delinassios G, Chiapero-Stanke L, Burbridge S, Mather SJ, Eccles SA et al. ( 2010 ) . Abstract 1932: Targeting the extended erbb receptor family using chimeric antigen receptor (CAR)-grafted t-cells as a treatment for head and neck cancer . Cancer Research . vol. 70 , 1932 - 1932 .
Wilkie S, Burbridge S, Davies DM, Chiapero-Stanke L, Foster J, Mather SJ, Maher J ( 2010 ) . Genetic engineering of pharmacologically regulated T cells, specific for breast cancer target antigens . BREAST CANCER RESEARCH . vol. 12 , S16 - S16 .
Sosabowski JK, Matzow T, Foster JM, Finucane C, Ellison D, Watson SA, Mather SJ ( 2009 ) . Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide . J Nucl Med vol. 50 , ( 12 ) 2082 - 2089 .
Sosabowski J, Matzow T, Foster J, Mather S ( 2009 ) . TARGETING OF CCK2 RECEPTOR EXPRESSING TUMOURS USING AN 111IN-LABELLED MINIGASTRIN DIMER . J LABELLED COMPD RAD vol. 52 , S327 - S327 .
Wilkie S, Picco G, Foster J, Davies DM, Julien S, Cooper L, Arif S, Mather SJ et al. ( 2008 ) . Retargeting of human T cells to tumor-associated MUC1: The evolution of a chimeric antigen receptor . J IMMUNOL vol. 180 , ( 7 ) 4901 - 4909 .
Wilkie S, Picco G, Foster J, Davies D, Julien S, Cooper L, Arif S, Mather S et al. ( 2008 ) . Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes . BREAST CANCER RESEARCH . vol. 10 , S4 - S5 .